W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.

FDA approves first venous stent for IVC and iliofemoral veins, offering a new treatment for deep venous disease with proven 12-month patency.

A self-expanding nitinol stent is associated with high patency and durability in patients with atherosclerotic popliteal artery disease, according to a study published in the January 2013 issue of ...

A study found that a nitinol stent performed better than balloon angioplasty alone in treating blockages of the popliteal artery, which runs through the leg behind the knee. Results of the ETAP trial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Two-year data from the Mimics study ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The final 3-year outcomes of the SUPERB trial showed ...

Gastric-outlet obstruction (GOO) refers to mechanical or functional obstruction of the flow of gastric contents into the small intestine. Symptoms of GOO include early satiety, postprandial abdominal ...

Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Nitinol Medical Devices - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Nitinol Medical ...

As an extremely versatile product, nickel-titanium (nitinol) has been in high demand for the production of various medical devices since well before the start of the coronavirus pandemic. Today, a ...